Biotech might be one of the riskiest sectors to invest in, but it’s also one of the most exciting and has potential for major returns. As pharmaceutical companies develop new lifesaving drugs and technologies, there are millions of dollars to be made by investors – as long as you know what to look for. Chief Income Strategist Marc Lichtenfeld shares his insights and expertise in the biotech and healthcare spheres to help you cash in.
We touched a nerve last week. And one thing is clear: Something has gone completely wrong with the state of our union.